# Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer

> **NCT03011255** · PHASE2 · UNKNOWN · sponsor: **Shixiu Wu** · enrollment: 20 (estimated)

## Conditions studied

- Esophageal Neoplasms
- Esophageal Diseases
- Digestive System Diseases

## Interventions

- **BIOLOGICAL:** peptide specific CTL

## Key facts

- **NCT ID:** NCT03011255
- **Lead sponsor:** Shixiu Wu
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2017-08
- **Final completion:** 2019-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03011255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03011255, "Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03011255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*